BES 2020

General assembly  
B. Velkeniers (VUB), President

Part 1: Translational and clinical studies

• Intestinal delivery of proinsulin and IL-10 via Lactococcus latis combined with low-dose antiCD3 induces antigen-specific FoxP3+ Tregs in autoimmune diabetic mice.
  Pieter-Jan Martens (KUL)
  
  
• YIPF5 mutations cause diabetes and microcephaly through disrupted endoplasmic reticulum-to-Golgi trafficking.
  Maria Lytrivi (ULB)
  
  
• Sexual symptoms predict all-cause mortality independently of sex steroids in ageing men.
  Leen Antonio (KUL)
  
  
• Soft drink intake on time of hypoglycaemia during insulin tolerance test: effects on pituitary response and comfort for the patient.
  Coralie Thiry (ULB)
  
  
• Chronic complications versus glycaemic variability, time in range and HbA1c in people with type 1 diabetes: sub study of the RESCUE-trial.
  Anass El Malahi (UAntwerp)
  

 Part 2: Clinical case reports.

• An unusual cause of unilateral adrenal incidentaloma.
  Younes Azzagnuni (ULB)
  
  
• A case of a heterozygous inactivating CASR variant with adult-onset symptomatic hypercalcemia requiring extensive surgery.
  Laurens Veldeman (UGhent)

Selected Belgian Publication Award (sponsored by Sandoz)

Introduced by B. Velkeniers (VUB), President

Clara Depommier et al. Nature Medicine 2019 (25): 1096–1103.
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study.

Presenting author: Clara Depommier (UCL)

Belgian Endocrine Society Lecture Award.

Introduced by B. Velkeniers (VUB), President

Advanced therapies that improve glucose control and quality of life of people with type 1 diabetes.
Award winner: Pieter Gillard (KUL)